Belsomra and Diplopia - a phase IV clinical study of FDA data
Summary:
Diplopia is reported as a side effect among people who take Belsomra (suvorexant), especially for people who are female, 40-49 old, have been taking the drug for 6 - 12 months also take Revatio, and have Gait disturbance.
The phase IV clinical study analyzes which people have Diplopia when taking Belsomra. It is created by eHealthMe based on reports of 12,886 people who have side effects when taking Belsomra from the FDA, and is updated regularly.
What is Belsomra?
Belsomra has active ingredients of suvorexant. It is often used in insomnia. eHealthMe is studying from 12,961 Belsomra users. Check the latest studies of Belsomra.
What is Diplopia?
Diplopia (double vision) is found to be associated with 1,427 drugs and 1,895 conditions by eHealthMe. Check the latest studies of Diplopia.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
12,886 people reported to have side effects when taking Belsomra.
Among them, 13 people (0.1%) have Diplopia.

Among these 13 people:
How long have people been on Belsomra when they have Diplopia? *
- < 1 month: 0.0 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 50 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 50 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Diplopia when taking Belsomra? *
- female: 53.85 %
- male: 46.15 %
What is the age of people who have Diplopia when taking Belsomra? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 50.0 %
- 50-59: 33.33 %
- 60+: 16.67 %
What are other drugs people take besides Belsomra? *
- Advil: 4 people, 30.77%
- Ampyra: 4 people, 30.77%
- Vitamin D3: 4 people, 30.77%
- Tysabri: 4 people, 30.77%
- Revatio: 4 people, 30.77%
- Norco: 3 people, 23.08%
- Benzonatate: 2 people, 15.38%
- Mirabegron: 2 people, 15.38%
- Zolpidem: 2 people, 15.38%
- Fluticasone Propionate: 2 people, 15.38%
What are other side effects people have besides Diplopia? *
- Vision Blurred: 10 people, 76.92%
- Bruxism (habitual grinding of the teeth, typically during sleep): 8 people, 61.54%
- Stress And Anxiety: 7 people, 53.85%
- Depression: 7 people, 53.85%
- Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 38.46%
- Chills (felling of cold): 5 people, 38.46%
- High Blood Pressure: 5 people, 38.46%
- Drowsiness: 5 people, 38.46%
- Dizziness: 5 people, 38.46%
- Photosensitivity Reaction: 5 people, 38.46%
What are the existing conditions these people have? *
- Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 4 people, 30.77%
- Gait Disturbance: 4 people, 30.77%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 23.08%
- Movement - Uncoordinated: 2 people, 15.38%
- High Blood Pressure: 2 people, 15.38%
- Secondary Progressive Multiple Sclerosis (a stage of ms which comes after relapsing remitting ms in many cases): 1 person, 7.69%
- Restless Leg Syndrome (a powerful urge to move your legs): 1 person, 7.69%
- Pulmonary Tuberculosis (lungs tuberculosis): 1 person, 7.69%
- Pain: 1 person, 7.69%
- Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles): 1 person, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Belsomra and have Diplopia?
- Check whether Diplopia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Belsomra:
- Belsomra (12,961 reports)
Diplopia treatments and more:
- Diplopia (32,466 reports)
How severe was Diplopia and when was it recovered:
Expand to all the drugs that have ingredients of suvorexant:
- Diplopia and drugs with ingredients of suvorexant (13 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Belsomra:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Diplopia:
- Diplopia (1,427 drugs)
Browse all the conditions that are associated with Diplopia:
- Diplopia (1,895 conditions)
Related publications that referenced our studies
- Kocamaz, M., & Karadag, O., "Topiramate-Induced Acute Myopia, Diplopia, and Photosensitivity: A Case Report", Beyoglu Eye Journal, 2019 Jan .
- Kocamaz, M., & Karadag, O., "Topiramate-Induced Acute Myopia, Diplopia, and Photosensitivity: A Case Report", Beyoglu Eye Journal, 2019 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on suvorexant (the active ingredients of Belsomra) and Belsomra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Buspar cause Dementia Alzheimer'S Type? - a second ago
- Dementia Alzheimer'S Type and Bradycardia - a second ago
- Drug interactions of Sodium Polystyrene Sulfonate and Atacand - 2 seconds ago
- Could Apixaban cause Drug Level Below Therapeutic? - 3 seconds ago
- Could Soliris cause Complement Factor C3 Decreased? - 4 seconds ago
- Could Apixaban cause Face Oedema? - 4 seconds ago
- Could Buprenorphine cause Migraine Aggravated? - 7 seconds ago
- Drug interactions of Xalatan and Ritalin - 8 seconds ago
- Could Soliris cause Progressive Multifocal Leukoencephalopathy? - 10 seconds ago
- Nasopharyngitis and Urinary Incontinence - 11 seconds ago